Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Cerebrovascular Disease: later-stage trial registry

2 of 8 indexed Cerebrovascular Disease trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Cerebrovascular Disease: 8 US clinical trials tracked, 2 recruiting.

Cerebrovascular Disease is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Aventusoft, running 1 of these trials.

Enrollment posture brief

Registry condition cerebrovascular-disease

OPEN 2 | RECR 25% | LATE 1 | EARLY 0 | RANK #2176 | SPON 1

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Cerebrovascular Disease (thi…25%
Open-enrollment share among volume-matched conditions near Cerebrovascular Disease

Cerebrovascular Disease lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cerebrovascular Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cerebrovascular Disease is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Cerebrovascular Disease trials is spread across many organizations.

    Aventusoft accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cerebrovascular Disease enrolment sits around 199 participants.

    Median target enrolment is 199 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.

  4. Cerebrovascular Disease research leans observational.

    2 interventional and 6 observational studies make up this index (25% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Cerebrovascular Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Anti-hypertensive therapy to SBP 145 mm Hg Other
1 trials
Anti-hypertensive therapy to SBP 130 mm Hg Other
1 trials
Modified Atkins or Ketogenic Diet Dietary supplement
1 trials
Hemotag Device
1 trials
Do-not-resuscitate (DNR) or withdrawal of care Other
1 trials
Hyperglycemia treatment Other
1 trials
Treatment of pyrexia Other
1 trials
Early intensive blood pressure lowering Other
1 trials

US sites by state

Facility locations filed on Cerebrovascular Disease trials. A trial with sites in several states counts in each.

Maryland 4 trials
Florida 2 trials
Texas 1 trials
Oklahoma 1 trials
Michigan 1 trials
Illinois 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cerebrovascular Disease page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Cerebrovascular Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Aventusoft sponsors the most Cerebrovascular Disease trials on record, review their full trial history before evaluating a specific study. See Aventusoft's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cerebrovascular Disease condition card totals 8 registered trials; most-linked intervention Anti-hypertensive therapy to SBP 145 mm Hg; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.